Results 101 to 110 of about 685 (145)

Development of muscle relaxants : potency and safety [PDF]

, 1996
van den Broek, Lambertus
core   +2 more sources

Anesthetic Considerations in a Patient with Type III Spinal Muscular Atrophy [PDF]

, 2022
Tsai, Elizabeth, Xu, Kevin, Zheng-Ward, Fei   +2 more
core  

Sodium bicarbonate supplementation prevents skilled tennis performance decline after a simulated match [PDF]

core   +1 more source

Novel Emergency Medicine Curriculum Utilizing Self-Directed Learning and the Flipped Classroom Method: Neurologic Emergencies Small Group Module [PDF]

, 2019
Bachmann, Daniel, Barrie, Michael, Chu, Alan, Kaide, Colin, King, Andrew, Leung, Cynthia, Malone, Matthew, McGrath, Jillian   +7 more
core  

Some of the next articles are maybe not open access.

Related searches:

Resistance to Nondepolarizing Neuromuscular Blocking Agents

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
Several case reports of resistance to short‐term administration of nondepolarizing neuromuscular blocking agents (NNMBAs) have been reported in research and surgical settings. Recently, several reports documented resistance to NNMBAs during therapy for prolonged paralysis in critically ill patients. Adverse outcomes associated with NNMBA resistance may
S J, Tschida, K J, Graupe, L L, Hoey, K, Vance-Bryan   +3 more
openaire   +2 more sources

Interaction Between Nondepolarizing Neuromuscular Blocking Agents and Inhalational Anesthetics

Anesthesia & Analgesia, 1989
Although many studies have presented data based on administration of nondepolarizing neuromuscular blocking agents to patients given inhalation anesthesia for 30-45 min, no data exist on the interaction in a clinical situation where the relaxant is administered immediately after the start of anesthesia.
Swen, J, Rashkovsky, O.M, Ket, J.M, Koot, H.W.J, Hermans, J, Agoston, S   +5 more
openaire   +3 more sources

Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids

Muscle & Nerve, 1994
AbstractThe long‐term use of nondepolarizing neuromuscular blocking agents (ND‐NMBA) has recently been implicated as a cause of prolonged muscle weakness, although the site of the lesion and the predisposing factors have been unclear. We report 3 patients (age 37–52 years) with acute respiratory insufficiency who developed prolonged weakness following ...
R J, Barohn, C E, Jackson, S J, Rogers, L W, Ridings, A L, McVey   +4 more
openaire   +2 more sources

The Quest for a Short‐Acting Nondepolarizing Neuromuscular Blocking Agent

Acta Anaesthesiologica Scandinavica, 1974
Current developments in the pharmacology of neuromuscular blocking agents indicate that within the next several years, nondepolarizing drugs of short and intermediate duration of action, devoid of significant side effects, may become a reality. The important factors which may permit their development are reviewed.
J J, Savarese, R J, Kitz
openaire   +2 more sources

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Survey of Anesthesiology, 2016
Abstract Background Residual postoperative paralysis from nondepolarizing neuromuscular blocking agents (NMBAs) is a known problem. This paralysis has been associated with impaired respiratory function, but the clinical significance remains unclear.
Catherine M, Bulka, Maxim A, Terekhov, Barbara J, Martin, Roger R, Dmochowski, Rachel M, Hayes, Jesse M, Ehrenfeld   +5 more
openaire   +2 more sources

Fumarates: Unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine

Journal of Critical Care, 2009
It has been almost 20 years since the introduction of the last new nondepolarizing neuromuscular blocking agent into clinical practice, and research is ongoing to fill a clinical need for a nondepolarizing agent with a fast onset of effect and a short duration of action, as described by Savarese and Kitz [1] in 1975.
Cynthia A, Lien, Peter, Savard, Matthew, Belmont, Hiorshi, Sunaga, John J, Savarese   +4 more
openaire   +2 more sources